Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ROCKET PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 92 shares of RCKT (ROCKET PHARMACEUTICALS INC), worth $323 as of 2025-Q4. The position was decreased (-99.6% shares).
Current Value
$323
Current Shares
92
Total Value Change
-$2.5M
Total Shares Change
-117,980
Other major holders of RCKT: BNP PARIBAS FINANCIAL MARKETS, RTW INVESTMENTS, LP
Decreased |
| 92 |
-99.6% |
| $323 |
| 0.0% |
| $3.42 |
0 |
| 2025-Q3 | Decreased | 21,922 | -92.3% | $71,466 | 0.0% | $3.28 | 0 |
| 2025-Q2 | Increased | 286,312 | +55.0% | $701,465 | 0.0% | $2.53 | 35 |
| 2025-Q1 | Increased | 184,692 | +32.3% | $1.2M | 0.0% | $7.59 | 32 |
| 2024-Q4 | Increased | 139,572 | +16.7% | $1.8M | 0.0% | $12.03 | 30 |
| 2024-Q3 | Increased | 119,633 | +1.3% | $2.2M | 0.0% | $18.46 | 26 |
| 2024-Q2 | Increased | 118,072 | +79.5% | $2.5M | 0.0% | $21.53 | 40 |